Fetomaternal alloimmune thrombocytopenia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
||
Line 5: | Line 5: | ||
In '''fetomaternal alloimmune thrombocytopenia''' (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for [[platelet]] antigens) pass through the [[placenta]] and attack platelets in the fetal circulation. This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed. Medical treatment is problematic. | In '''fetomaternal alloimmune thrombocytopenia''' (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for [[platelet]] antigens) pass through the [[placenta]] and attack platelets in the fetal circulation. This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed. Medical treatment is problematic. | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] |
Revision as of 02:40, 9 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In fetomaternal alloimmune thrombocytopenia (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for platelet antigens) pass through the placenta and attack platelets in the fetal circulation. This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed. Medical treatment is problematic. Template:WH Template:WikiDoc Sources